Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Investigating motor and NMJ synaptic defects in a zebrafish STMN2 loss-of-function model

FY 2021-22

Summary
The development of novel animal models remains a critical tool for researchers investigating mechanisms of neurodegeneration and for the development of therapeutics to treat amyotrophic lateral sclerosis (ALS). My project seeks to explore the cellular and behavioural consequences of reduced Stathmin-2 (STMN2) levels on motor axon development and function and to explore the ability to rescue disease-related motor phenotypes using zebrafish. The transcript encoding STMN2 has emerged as an important cellular target of the RNA binding protein TDP-43, that in disease, results in an alternatively spliced cryptic exon encoding a truncated and non-functional STMN2 variant. This proposal will add to our understanding of STMN2s role in stabilizing motor axon projections to neuromuscular junctions (NMJ) and will likely be useful for ensuing experiments including potential therapies for ALS. Zebrafish are an ideal model system as I will be able to explore both the disease mechanisms and evaluate the potential of restorative constructs that rescue loss or mis-regulation of STMN2 using live cellular imaging to track motor axon projections in vivo. Using the CRISPR/cas9 mutagenic system I have identified several gRNAs that cleave DNA and am currently raising mutant fish lines which will be selected for Stmn2 knockouts (KO). I hypothesize that my zebrafish Stmn2 KO model will display reduced motor function and NMJ defects characterized by cellular imaging of ventral root projections and through behavioural studies. I will attempt to rescue synaptic and motor function through injection of human STMN2 mRNA into developing Stmn2 KO blastocysts. I hypothesize that human STMN2 mRNA will restore motor function in our Stmn2 KO models, opening the door to future clinical tools to treat ALS.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466563
Name
Gurberg Tyler
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating motor and NMJ synaptic defects in a zebrafish STMN2 loss-of-function model
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Als; Crispr; Knock-Out; Microscopy; Neurodegeneration; Neuron; Stathmin-2; Stmn2; Tdp-43; Zebrafish
Abstract
The development of novel animal models remains a critical tool for researchers investigating mechanisms of neurodegeneration and for the development of therapeutics to treat amyotrophic lateral sclerosis (ALS). My project seeks to explore the cellular and behavioural consequences of reduced Stathmin-2 (STMN2) levels on motor axon development and function and to explore the ability to rescue disease-related motor phenotypes using zebrafish. The transcript encoding STMN2 has emerged as an important cellular target of the RNA binding protein TDP-43, that in disease, results in an alternatively spliced cryptic exon encoding a truncated and non-functional STMN2 variant. This proposal will add to our understanding of STMN2s role in stabilizing motor axon projections to neuromuscular junctions (NMJ) and will likely be useful for ensuing experiments including potential therapies for ALS. Zebrafish are an ideal model system as I will be able to explore both the disease mechanisms and evaluate the potential of restorative constructs that rescue loss or mis-regulation of STMN2 using live cellular imaging to track motor axon projections in vivo. Using the CRISPR/cas9 mutagenic system I have identified several gRNAs that cleave DNA and am currently raising mutant fish lines which will be selected for Stmn2 knockouts (KO). I hypothesize that my zebrafish Stmn2 KO model will display reduced motor function and NMJ defects characterized by cellular imaging of ventral root projections and through behavioural studies. I will attempt to rescue synaptic and motor function through injection of human STMN2 mRNA into developing Stmn2 KO blastocysts. I hypothesize that human STMN2 mRNA will restore motor function in our Stmn2 KO models, opening the door to future clinical tools to treat ALS.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gurberg, Tyler
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~